A Trial Comparing the Pharmacokinetic and Pharmacodynamic Properties Between NN5401 and NN1250 and Between NN5401 and Insulin Aspart in Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Insulin aspart; Insulin degludec; Insulin degludec/insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Aug 2010 New trial record